Total Payments
$8,450
2024 Payments
$18.50
Companies
43
Transactions
338
Medicare Patients
2,193
Medicare Billing
$255,326
Payment Breakdown by Category
Food & Beverage$7,036 (83.3%)
Consulting$1,200 (14.2%)
Education$188.38 (2.2%)
Travel$25.23 (0.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,036 | 330 | 83.3% |
| Consulting Fee | $1,200 | 1 | 14.2% |
| Education | $188.38 | 6 | 2.2% |
| Travel and Lodging | $25.23 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Biohaven Pharmaceuticals, Inc. | $1,360 | 9 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $1,282 | 46 | $0 (2023) |
| Novo Nordisk Inc | $1,149 | 57 | $0 (2023) |
| Allergan, Inc. | $952.07 | 53 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $642.49 | 15 | $0 (2020) |
| ABBVIE INC. | $500.41 | 21 | $0 (2023) |
| Lilly USA, LLC | $439.57 | 25 | $0 (2023) |
| PFIZER INC. | $253.92 | 14 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $237.99 | 18 | $0 (2019) |
| Merck Sharp & Dohme LLC | $235.78 | 10 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $18.50 | 1 | Janssen Biotech, Inc. ($18.50) |
| 2023 | $483.05 | 22 | Penumbra, Inc. ($72.55) |
| 2022 | $676.60 | 33 | Novo Nordisk Inc ($192.98) |
| 2021 | $2,335 | 57 | Biohaven Pharmaceuticals, Inc. ($1,360) |
| 2020 | $925.15 | 37 | Allergan, Inc. ($443.82) |
| 2019 | $1,294 | 53 | Novo Nordisk Inc ($326.87) |
| 2018 | $956.23 | 56 | Boehringer Ingelheim Pharmaceuticals, Inc. ($201.59) |
| 2017 | $1,762 | 79 | AstraZeneca Pharmaceuticals LP ($532.22) |
All Payment Transactions
338 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/24/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $18.50 | General |
| Category: Immunology | ||||||
| 12/18/2023 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $15.97 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 10/30/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $24.79 | General |
| Category: PAIN | ||||||
| 10/23/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: Diabetes | ||||||
| 09/21/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: Inflammation | ||||||
| 08/10/2023 | PFIZER INC. | PAXLOVID (Drug), NURTEC ODT, ZAVZPRET | Food and Beverage | In-kind items and services | $25.44 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 08/08/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $14.69 | General |
| Category: Oncology | ||||||
| 07/28/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $21.13 | General |
| Category: INSOMNIA | ||||||
| 07/17/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/11/2023 | Currax Pharmaceuticals LLC | NEXLETOL (Drug) | Education | In-kind items and services | $25.00 | General |
| Category: Cholesterol Reducer | ||||||
| 06/12/2023 | Penumbra, Inc. | Real Immersive System (Device) | Food and Beverage | Cash or cash equivalent | $49.57 | General |
| Category: Neuro Rehabilitation | ||||||
| 06/12/2023 | Penumbra, Inc. | Real Immersive System (Device) | Food and Beverage | Cash or cash equivalent | $22.98 | General |
| Category: Neuro Rehabilitation | ||||||
| 06/07/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $18.52 | General |
| Category: Immunology | ||||||
| 05/25/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $27.83 | General |
| Category: UROLOGY | ||||||
| 05/25/2023 | Azurity Pharmaceuticals, Inc. | Edarbi (Drug) | Food and Beverage | Cash or cash equivalent | $18.60 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/23/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $27.12 | General |
| Category: NEUROSCIENCE | ||||||
| 05/01/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $24.77 | General |
| Category: Immunology | ||||||
| 04/24/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.58 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/19/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $17.47 | General |
| Category: Oncology | ||||||
| 03/09/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $20.15 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/08/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.42 | General |
| Category: Obesity | ||||||
| 01/19/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/04/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $23.99 | General |
| Category: INSOMNIA | ||||||
| 12/13/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $14.62 | General |
| Category: NEUROSCIENCE | ||||||
| 11/01/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $21.41 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 455 | 659 | $158,544 | $60,706 |
| 2022 | 11 | 608 | 849 | $188,052 | $75,589 |
| 2021 | 13 | 659 | 863 | $184,799 | $76,223 |
| 2020 | 9 | 471 | 605 | $137,497 | $42,808 |
Total Patients
2,193
Total Services
2,976
Medicare Billing
$255,326
Procedure Codes
42
All Medicare Procedures & Services
42 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 137 | 277 | $56,234 | $19,344 | 34.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 123 | 123 | $32,140 | $17,810 | 55.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 98 | 153 | $46,053 | $14,615 | 31.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 24 | 28 | $11,480 | $4,468 | 38.9% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 11 | 12 | $7,200 | $2,988 | 41.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 18 | 19 | $1,125 | $649.96 | 57.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 11 | 12 | $1,544 | $512.70 | 33.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 22 | 23 | $2,300 | $276.36 | 12.0% |
| 81002 | Urinalysis, manual test | Office | 2023 | 11 | 12 | $468.00 | $40.92 | 8.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 133 | 285 | $57,858 | $20,794 | 35.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 126 | 126 | $32,924 | $18,884 | 57.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 115 | 172 | $51,772 | $17,789 | 34.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 36 | 42 | $17,220 | $6,120 | 35.5% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 16 | 23 | $13,800 | $5,916 | 42.9% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 11 | 11 | $4,261 | $2,115 | 49.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 52 | 54 | $3,375 | $1,873 | 55.5% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2022 | 55 | 58 | $2,030 | $1,220 | 60.1% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 13 | 13 | $812.50 | $454.39 | 55.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 23 | 24 | $2,400 | $280.54 | 11.7% |
| 81002 | Urinalysis, manual test | Office | 2022 | 28 | 41 | $1,599 | $140.30 | 8.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 122 | 234 | $47,504 | $18,089 | 38.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 112 | 112 | $29,266 | $17,164 | 58.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 102 | 164 | $49,364 | $16,452 | 33.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 48 | 63 | $25,830 | $9,838 | 38.1% |
| 90670 | Pneumococcal vaccine for injection into muscle | Office | 2021 | 24 | 25 | $9,035 | $5,794 | 64.1% |
About Dr. Robert Ginsberg, M.D
Dr. Robert Ginsberg, M.D is a Family Medicine healthcare provider based in Burtonsville, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1801820964.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Ginsberg, M.D has received a total of $8,450 in payments from pharmaceutical and medical device companies, with $18.50 received in 2024. These payments were reported across 338 transactions from 43 companies. The most common payment nature is "Food and Beverage" ($7,036).
As a Medicare-enrolled provider, Ginsberg has provided services to 2,193 Medicare beneficiaries, totaling 2,976 services with total Medicare billing of $255,326. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Burtonsville, MD
- Active Since 07/11/2006
- Last Updated 12/17/2012
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1801820964
Products in Payments
- NURTEC ODT (Drug) $1,472
- UBRELVY (Drug) $816.09
- FARXIGA (Drug) $762.21
- JARDIANCE (Drug) $616.67
- Saxenda (Drug) $477.79
- Trintellix (Drug) $251.64
- Ozempic (Drug) $236.27
- BYSTOLIC (Drug) $206.09
- TRULICITY (Drug) $192.88
- XIGDUO (Drug) $184.03
- Victoza (Drug) $181.81
- BELSOMRA (Drug) $172.31
- VRAYLAR (Drug) $143.28
- TOUJEO (Drug) $130.30
- LINZESS (Drug) $130.24
- CHANTIX (Drug) $104.17
- BEVESPI AEROSPHERE (Drug) $103.57
- BYDUREON (Drug) $97.50
- QULIPTA (Drug) $95.20
- Dayvigo (Drug) $93.47
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.